drugset / Trial / NCT02964260
RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Unknown
410 enrolled
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University · collabGuangdong Provincial People's Hospital · collabSixth Affiliated Hospital, Sun Yat-sen University · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabThird Affiliated Hospital, Sun Yat-Sen University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study intends to evaluate the efficacy and safety of Transarterial embolization (TAE) simultaneously combined with thermal ablation for large hepatocellular carcinoma (HCC). Half participants will receive TAE simultaneously combined with thermal ablation and the other half receive TACE sequentially combined with thermal ablation, which is a conventional treatment for HCC patients.
Timeline
- Start
- 2016-05
- Primary completion
- 2022-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | — |